Skip to content
zameds

Oxcarbazepine

Sold as Oxcarbazepine viatris, Eizurex, Ruzecin, Ruzexin, Trileptal

S3
Loading the molecular structure
C15H12N2O2252.27 g/mol

5-Oxo-6H-benzo[b][1]benzazepine-11-carboxamide

Drag to rotate. Structure from PubChem CID 34312.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
3
Registrations
11
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Viatris South Africa (Pty) LtdOxcarbazepine viatris150, 300, 600411106, 420354, 420355S3None
Hetero Drugs South Africa (Pty) LtdEizurex, Ruzecin, Ruzexin150, 300, 600570209, 570210, 570211, 570212.209, 570213.210, 570214.211S3PIPIL
Novartis South Africa (Pty) LtdTrileptal300, 600X0205, X0206S3PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Oxcarbazepine 600 viatris

EACH TABLET CONTAINS OXCARBAZEPINE 600,0 mg

60041110641/2.5/1106RegisteredS3None
Oxcarbazepine 150 viatris

EACH TABLET CONTAINS :OXCARBAZEPINE 150,0 mg

15042035442/2.5/0354RegisteredS3None
Oxcarbazepine 300 viatris

EACH TABLET CONTAINS :OXCARBAZEPINE 300,0 mg

30042035542/2.5/0355RegisteredS3None
Eizurex 150

EACH TABLET CONTAINS OXCARBAZEPINE 150,0 mg

150Film-coated tablet57020957/2.5/0209Approved 25 March 2025RegisteredS3PIPIL
Eizurex 300

EACH TABLET CONTAINS OXCARBAZEPINE 3000,0 mg

300Film-coated tablet57021057/2.5/0210Approved 25 March 2025RegisteredS3PIPIL
Eizurex 600

EACH TABLET CONTAINS OXCARBAZEPINE 600,0 mg

600Film-coated tablet57021157/2.5/0211Approved 25 March 2025RegisteredS3PIPIL
Ruzecin 150

EACH TABLET CONTAINS OXCARBAZEPINE 150,0 mg

150570212.20957/2.5/212.209RegisteredS3None
Ruzexin 300

EACH TABLET CONTAINS OXCARBAZEPINE 300,0 mg

300Film-coated tablet570213.21057/2.5/0213.210Approved 25 March 2025RegisteredS3PIPIL
Ruzexin 600

EACH TABLET CONTAINS OXCARBAZEPINE 600,0 mg

600Film-coated tablet570214.21157/2.5/0214.211Approved 25 March 2025RegisteredS3PIPIL
Trileptal 300

EACH TABLET CONTAINS OXCARBAZEPINE 300 mg

300Film-coated tabletsX0205X/2.5/205Approved 14 September 2022RegisteredS3PIPIL
Trileptal 600

EACH TABLET CONTAINS OXCARBAZEPINE 600 mg

600Film-coated tabletsX0206X/2.5/206Approved 14 September 2022RegisteredS3PIPIL

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Oxcarbazepine

  • S3: Oxcarbazepine

    Consolidated Schedules 06 July 2026, line 4077

Pharmacological class: Anticonvulsants, including anti-epileptics. (class 2.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Eizurex 150, Hetero Drugs South Africa (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsEizurex 150, Hetero Drugs South Africa (Pty) LtdPatient information leaflet (PIL)For patients and carersEizurex 150, Hetero Drugs South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles